John H. Rutherford sold Bristol-Myers Squibb Company (NYSE: BMY)
John H. Rutherford (R-FL), a U.S. Representative, has disclosed 5 trades in Bristol-Myers Squibb Company (BMY) since 2017, 3 purchases and 2 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: John H. Rutherford sold $1,001 - $15,000 of Bristol-Myers Squibb Company (NYSE: BMY) on July 10, 2019. Since that trade, BMY is up +77.24% against the S&P 500 up +169.87%, an outperformance of -92.63%.
Across these filings, John H. Rutherford has been a net buyer of BMY (a buy-to-sell ratio of 1.50). The most recent disclosed BMY transaction shown was dated March 16, 2022. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
John H. Rutherford's BMY trades vs the price
BMY is up +77.24% since John H. Rutherford sold on July 10, 2019, versus +169.87% for the S&P 500.
Performance since this trade
All John H. Rutherford BMY trades
| Traded | Type | Size | Return | Est. profit | |
|---|---|---|---|---|---|
| March 16, 2022 | SELL | $58.38 | +8.09% | — | |
| July 21, 2020 | BUY | $47.79 | +32.03% | +$441 | |
| June 21, 2020 | BUY | $44.74 | +41.03% | +$949 | |
| July 10, 2019 | SELL | $35.60 | +77.24% | — | |
| August 16, 2017 | BUY | $42.03 | +50.13% | +$779 |
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
John H. Rutherford & BMY trading FAQ
Is it legal for John H. Rutherford to trade Bristol-Myers Squibb Company (BMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Bristol-Myers Squibb Company (BMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did John H. Rutherford sell BMY?
John H. Rutherford disclosed a sale of $1,001 - $15,000 of Bristol-Myers Squibb Company (BMY) on July 10, 2019, according to public STOCK Act filings.
How has BMY performed since John H. Rutherford's trade?
Since John H. Rutherford sold BMY on July 10, 2019, the stock is up +77.24%, versus +169.87% for the S&P 500 over the same period, an outperformance of -92.63%.
How many times has John H. Rutherford traded BMY?
John H. Rutherford has disclosed 5 BMY trades since 2017 (3 purchases and 2 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BMY trades?
Quantellect tracks every disclosed congressional trade in Bristol-Myers Squibb Company (BMY) on the Bristol-Myers Squibb Company congressional trading page, which aggregates filings across all members of Congress.
John H. Rutherford's BMY tradesAll congressional filings for Bristol-Myers Squibb CompanyJohn H. Rutherford's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.